Insider Stock Trading History of Baity Glenn


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baity Glenn since year 2005. The trader's CIK number is 1487100. At the time of this reporting, Baity Glenn is the EVP AND GC of Acadia Pharmaceuticals Inc . (stock ticker symbol ACAD). See this page for all insider trading activities at Acadia Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Baity Glenn since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-04 ACAD Acadia Pharmaceuticals Inc Option Ex 11,000 1.90 20,900
2017-10-05 ACAD Acadia Pharmaceuticals Inc Option Ex 28,500 1.93 55,090
2017-10-05 ACAD Acadia Pharmaceuticals Inc Sale 37,500 40.91 1,534,050
2017-08-30 ACAD Acadia Pharmaceuticals Inc Option Ex 16,507 1.62 26,741
2017-08-30 ACAD Acadia Pharmaceuticals Inc Sale 26,507 34.87 924,325
2017-08-09 ACAD Acadia Pharmaceuticals Inc Sale 14,322 34.88 499,537
2017-08-09 ACAD Acadia Pharmaceuticals Inc Option Ex 14,322 1.58 22,700
2017-08-04 ACAD Acadia Pharmaceuticals Inc Option Ex 6,500 1.62 10,530
2017-07-20 ACAD Acadia Pharmaceuticals Inc Option Ex 28,097 1.62 45,517
2017-07-20 ACAD Acadia Pharmaceuticals Inc Sale 38,097 30.00 1,142,910
2017-06-22 ACAD Acadia Pharmaceuticals Inc Option Ex 1,903 1.62 3,082
2017-06-22 ACAD Acadia Pharmaceuticals Inc Sale 1,903 30.00 57,090
2017-05-15 ACAD Acadia Pharmaceuticals Inc Option Ex 14,093 1.62 22,830
2017-02-14 ACAD Acadia Pharmaceuticals Inc Option Ex 26,365 4.98 131,297
2017-02-14 ACAD Acadia Pharmaceuticals Inc Sale 26,365 39.66 1,045,530
2017-02-01 ACAD Acadia Pharmaceuticals Inc Option Ex 21,078 1.55 32,670
2017-02-01 ACAD Acadia Pharmaceuticals Inc Sale 31,078 35.15 1,092,391
2016-12-27 ACAD Acadia Pharmaceuticals Inc Sale 9,800 30.46 298,478
2016-12-28 ACAD Acadia Pharmaceuticals Inc Option Ex 5,500 1.62 8,910
2016-12-27 ACAD Acadia Pharmaceuticals Inc Option Ex 9,800 1.55 15,190
2016-12-19 ACAD Acadia Pharmaceuticals Inc Option Ex 8,635 1.64 14,161
2016-12-20 ACAD Acadia Pharmaceuticals Inc Option Ex 10,000 1.55 15,500
2016-12-20 ACAD Acadia Pharmaceuticals Inc Sale 10,000 30.00 300,000
2016-11-10 ACAD Acadia Pharmaceuticals Inc Option Ex 10,200 1.55 15,810
2016-11-10 ACAD Acadia Pharmaceuticals Inc Sale 10,200 30.07 306,683
2016-07-11 ACAD Acadia Pharmaceuticals Inc Option Ex 4,057 6.78 27,506
2016-07-12 ACAD Acadia Pharmaceuticals Inc Option Ex 11,943 6.78 80,973
2016-07-11 ACAD Acadia Pharmaceuticals Inc Sale 4,057 35.00 142,003
2016-07-12 ACAD Acadia Pharmaceuticals Inc Sale 11,943 35.00 418,028
2014-12-09 ACAD Acadia Pharmaceuticals Inc Option Ex 8,000 1.55 12,400
2014-02-26 ACAD Acadia Pharmaceuticals Inc Sale 42,000 30.28 1,271,718
2014-02-26 ACAD Acadia Pharmaceuticals Inc Option Ex 42,000 6.17 259,140
2013-04-22 ACAD Acadia Pharmaceuticals Inc Option Ex 10,000 1.62 16,200
2013-04-22 ACAD Acadia Pharmaceuticals Inc Sale 10,000 13.15 131,490
2013-04-16 ACAD Acadia Pharmaceuticals Inc Option Ex 20,000 1.55 31,000
2013-04-15 ACAD Acadia Pharmaceuticals Inc Option Ex 20,000 1.55 31,000
2013-04-17 ACAD Acadia Pharmaceuticals Inc Sale 10,000 12.26 122,600
2013-04-16 ACAD Acadia Pharmaceuticals Inc Sale 20,000 12.30 246,000
2013-04-17 ACAD Acadia Pharmaceuticals Inc Option Ex 10,000 1.55 15,500
2013-04-15 ACAD Acadia Pharmaceuticals Inc Sale 20,000 12.50 250,000
2013-04-12 ACAD Acadia Pharmaceuticals Inc Sale 30,000 12.87 386,100
2013-04-11 ACAD Acadia Pharmaceuticals Inc Sale 30,000 12.02 360,600
2013-04-12 ACAD Acadia Pharmaceuticals Inc Option Ex 30,000 1.57 47,190
2013-04-11 ACAD Acadia Pharmaceuticals Inc Option Ex 30,000 1.57 47,190
2013-04-02 ACAD Acadia Pharmaceuticals Inc Sale 13,163 8.00 105,304
2012-11-27 ACAD Acadia Pharmaceuticals Inc Sale 16,206 6.28 101,757
2012-11-28 ACAD Acadia Pharmaceuticals Inc Sale 4,396 5.25 23,092

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baity Glenn (EVP AND GC of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.